Acta Neurologica Belgica, volume 116, issue 4, pages 439-443
MtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis
Sasan Andalib
1
,
Mohammadreza Emamhadi
1
,
Shahrokh Yousefzadeh Chabok
1
,
Arsalan Salari
2
,
Abdolhosein Emami Sigaroudi
3
,
Manouchehr Seyedi Vafaee
4
Publication type: Journal Article
Publication date: 2016-07-25
Journal:
Acta Neurologica Belgica
scimago Q2
SJR: 0.580
CiteScore: 4.2
Impact factor: 2
ISSN: 03009108, 03009009, 22402993
General Medicine
Neurology (clinical)
Abstract
MtDNA T4216C variation has frequently been investigated in Multiple Sclerosis (MS) patients; nonetheless, controversy has existed about the evidence of association of this variation with susceptibility to MS. The present systematic review and meta-analysis converge the results of the preceding publications, pertaining to association of mtDNA T4216C variation with susceptibility to MS, into a common conclusion. A computerized literature search in English was carried out to retrieve relevant publications from which required data were extracted. Using a fixed effect model, pooled odds ratio (OR), 95 % confidence interval (95 % CI), and P value were calculated for association of mtDNA T4216C variation with susceptibility to MS. The pooled results showed that there was a significant association between mtDNA T4216C variation and MS (OR = 1.38, 95 % CI = 1.13–1.67, P = 0.001). The present systematic review and meta-analysis suggest that mtDNA T4216C variation is a contributory factor in susceptibility to MS.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.